Stomach
Sacrosidase
Enzyme
Other names: Sucraid
Wait
7 days
after the first dose
The FAA's MedGuide lists sacrosidase (Sucraid) as allowed, for congenital sucrase-isomaltase deficiency (CSID), with a wait of 7 days after the first dose and none after later doses or after the final dose, used as prescribed.
Track your medicationsMore detail: sacrosidaseThe rest of Crosscheck's reading, in plain wordsOpen
The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present, and says wait times are not determined solely by the medication: an extended observation period may be required to verify clinical stability of the condition.
- 7 days after the first dose: ground observation
Show the FAA's words: sacrosidaseThe official FAA wording: three passages, each with its document and dateOpen
Generic: sacrosidase
Brand Name: Sucraid
Drug Class: Enzyme
Underlying Condition: Congenital sucrase-isomaltase deficiency (CSID)
Use: ALLOW
INITIAL Wait Time (after first dose): 7 days
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
Underlying Condition: Evaluating medication use requires considering the impact of safety of flight from both the medication and underlying condition. Wait times are not determined solely by the medication; an extended observation period may be required to verify clinical stability of the condition.